Citigroup
PRVA icon

Citigroup’s Privia Health PRVA Stock Holding History

Citigroup’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
79,844
+53,338
+201% +$1.24M ﹤0.01% 2912
2026
Q1 		$545K Sell
26,506
-13,129
-33% -$296K ﹤0.01% 3498
2025
Q4 		$940K Sell
39,635
-20,748
-34% -$505K ﹤0.01% 3178
2025
Q3 		$1.5M Sell
60,383
-68,814
-53% -$1.48M ﹤0.01% 2903
2025
Q2 		$2.97M Sell
129,197
-54,531
-30% -$1.26M ﹤0.01% 2333
2025
Q1 		$4.12M Buy
183,728
+8,516
+5% +$198K ﹤0.01% 2073
2024
Q4 		$3.43M Buy
175,212
+20,646
+13% +$409K ﹤0.01% 2335
2024
Q3 		$2.81M Buy
154,566
+51,306
+50% +$979K ﹤0.01% 2368
2024
Q2 		$1.79M Sell
103,260
-189,261
-65% -$3.35M ﹤0.01% 2437
2024
Q1 		$5.73M Buy
292,521
+217,969
+292% +$4.6M ﹤0.01% 1609
2023
Q4 		$1.72M Buy
74,552
+19,729
+36% +$442K ﹤0.01% 2373
2023
Q3 		$1.26M Sell
54,823
-19,201
-26% -$488K ﹤0.01% 2321
2023
Q2 		$1.93M Buy
74,024
+52,710
+247% +$1.39M ﹤0.01% 2250
2023
Q1 		$588K Buy
21,314
+18,926
+793% +$500K ﹤0.01% 3000
2022
Q4 		$54.2K Sell
2,388
-2,112
-47% -$58.8K ﹤0.01% 4251
2022
Q3 		$153K Sell
4,500
-1,760
-28% -$65.1K ﹤0.01% 3892
2022
Q2 		$182K Buy
6,260
+1,474
+31% +$37.5K ﹤0.01% 3899
2022
Q1 		$128K Sell
4,786
-1,033
-18% -$24.4K ﹤0.01% 4303
2021
Q4 		$151K Buy
5,819
+2,645
+83% +$65.9K ﹤0.01% 4512
2021
Q3 		$75K Sell
3,174
-26,936
-89% -$940K ﹤0.01% 4530
2021
Q2 		$1.34M Buy
+30,110
New +$1.11M ﹤0.01% 2997

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Citigroup's PRVA Position: Q2 2026 in Review

Citigroup increased its Privia Health (PRVA) stake by 201% in Q2 2026, buying an estimated $1.24M and bringing the position to 79,844 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2912.

Citigroup first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $5.73M in Q1 2024. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Citigroup held 79,844 shares of Privia Health worth $2.05M as of Q2 2026.
  • Citigroup bought 53,338 Privia Health shares in Q2 2026, an estimated $1.24M.
  • Privia Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2912 holding.
  • Citigroup first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Citigroup's Privia Health position peaked at $5.73M in Q1 2024.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.